
Hematology and Blood and Marrow Transplant
UCSF Hematology and Blood and Marrow Transplant is dedicated to providing the most advanced treatment options with care and compassion. Our physicians are trained in both hematology and blood and marrow transplant (BMT), giving patients more cohesive care and better access to transplants when needed. Patients come from across the western U.S. to be treated in our program.
UCSF is also home to a robust hematology and BMT research program, and interested patients may have the option to participate in clinical trials. These include studies of cutting-edge immunotherapy treatments such as tumor vaccines and CAR T-cell therapy.
As part of the UCSF Helen Diller Family Comprehensive Cancer Center, we offer our cancer patients access to many services, including support groups, exercise and mindfulness classes, psychosocial support, symptom management and much more.
Our program is a member of the Parker Institute for Cancer Immunotherapy, whose mission is to turn cancer into a curable disease by accelerating the development of breakthrough immune therapies.
Our locations
Patient education
Our team
Clinical trials
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin...
All subjects enrolled in this phase I study who actually received study drug (anti-CD19 CAR-T infusion) will be included in the analysis. Proportion of participants with treatment-emergent adverse events of CAR-T in B-cell NHL, as...
Recruiting
Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refract...
ORR is defined as stringent complete response (sCR) + complete response (CR) + very good partial response + partial response (PR) as best response using International Myeloma Working Group (IMWG) Uniform Response Criteria for all ...
Recruiting
Rankings & achievements
-
Best hospital in Northern California
-
Best in Northern California in cancer care
-
blood and marrow transplants performed each year
-
Founded in 1986
Accreditations & memberships
-
National Cancer Institute
The National Cancer Institute has designated UCSF a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
-
Commission on Cancer
UCSF's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
-
National Comprehensive Cancer Network
UCSF is a founding member of the National Comprehensive Cancer Network, an alliance of the world’s top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.
Support services
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your condition
- List of your medications, including dosages, plus any you're allergic to
- List of questions you may have
- Device or paper for taking notes

International Services
If you live in another country and are coming to UCSF for medical
treatment, our patient liaisons can help coordinate all aspects of your visit.

Interpreters
UCSF offers language services at no charge for patients with limited
English, as well as for patients who are deaf or have trouble hearing.

Hospital Stays
Checking into the hospital? Find helpful information by clicking on the relevant “Your Hospital Stay” booklet: Mission Bay, Parnassus or Mount
Zion.

Your Doctor Visit
See our top 10 tips for making your UCSF doctor’s appointment as stress-free and productive as possible.
Learn moreRelated clinics
Our research initiatives
-
UCSF Helen Diller Family Comprehensive Cancer Center Research
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.